|
KDM6A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63702384980979E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.20310469656715E-11 |
| Normal-vs-Stage2 |
1.46219999996866E-07 |
| Normal-vs-Stage3 |
9.05397978812061E-12 |
| Normal-vs-Stage4 |
2.78099765438355E-12 |
| Stage1-vs-Stage2 |
6.108400E-01 |
| Stage1-vs-Stage3 |
7.016000E-02 |
| Stage1-vs-Stage4 |
8.37650000000689E-05 |
| Stage2-vs-Stage3 |
4.194600E-01 |
| Stage2-vs-Stage4 |
1.117870E-02 |
| Stage3-vs-Stage4 |
5.691700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.48436818392383E-13 |
| Normal-vs-AfricanAmerican |
6.322400E-03 |
| Normal-vs-Asian |
5.30910000406948E-08 |
| Caucasian-vs-AfricanAmerican |
1.149980E-01 |
| Caucasian-vs-Asian |
8.997600E-01 |
| AfricanAmerican-vs-Asian |
2.022800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
6.88169998763755E-09 |
| Male-vs-Female |
<1E-12 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.92869999970924E-08 |
| Normal-vs-Age(41-60Yrs) |
2.09049999533306E-10 |
| Normal-vs-Age(61-80Yrs) |
3.30913074719774E-12 |
| Normal-vs-Age(81-100Yrs) |
6.804100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.612000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.100300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.276200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.107700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.716400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.106000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.204010E-02 |
| Classical-VS-Follicular |
3.984200E-01 |
| Classical-VS-Other |
6.688800E-01 |
| Classical-VS-Normal |
3.6551999982315E-08 |
| Tall-VS-Follicular |
1.272600E-01 |
| Tall-VS-Other |
8.347200E-01 |
| Tall-VS-Normal |
6.90689949678358E-10 |
| Follicular-VS-Other |
7.297000E-01 |
| Follicular-VS-Normal |
1.0860000010382E-08 |
| Other-VS-Normal |
8.177200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.39960315243593E-11 |
| Normal-vs-N1 |
1.39760003570188E-09 |
| N0-vs-N1 |
1.308250E-01 |
|
|
